Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
TIAA-CREF LARGE-CAP GROWTH FUND et al v. ALLERGAN PLC, et al
Case Number:
2:17-cv-11089
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
September 30, 2021
Allergan Must Face Generic Drug Price-Fixing Claims
A New Jersey federal judge Thursday nixed Allergan's bid to toss a generic drug price-fixing lawsuit on the grounds that funds affiliated with TIAA-CREF were too late in filing their claims since similar antitrust actions based on related government investigations were filed more than a year earlier.
-
January 30, 2020
Funds Say Allergan Wants '2nd Bite At Apple' Dismissal
Allergan shareholders on Wednesday told a New Jersey federal judge not to let the company slip their proposed securities class action accusing the company of keeping them in the dark about its purported role in antitrust schemes.
-
December 09, 2019
Allergan Aims To Sink Suit Over Generics Antitrust Claims
Allergan is asking a New Jersey federal court to throw out a securities suit from funds affiliated with TIAA-CREF alleging the pharmaceutical company kept investors in the dark about its purported role in antitrust schemes, saying the claims were filed too long after related government investigations were publicly revealed.
-
November 06, 2017
Allergan Hit With Securities Suit Over Generics Price-Fixing
Funds affiliated with TIAA-CREF slapped Allergan PLC with a securities suit in New Jersey federal court on Friday, alleging the company's stock was artificially inflated for years because its executives concealed its involvement in a widespread generic-drug price-fixing scandal.